Investigation of Safety of WS 1442 in Slightly Overweight Subjects With Pilot Assessment of Pharmacodynamic Effects of WS 1442 on Endothelial Function.

Trial Profile

Investigation of Safety of WS 1442 in Slightly Overweight Subjects With Pilot Assessment of Pharmacodynamic Effects of WS 1442 on Endothelial Function.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Jun 2014

At a glance

  • Drugs Crataegus (Primary)
  • Indications Obesity
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Dr. Willmar Schwabe Pharmaceuticals
  • Most Recent Events

    • 13 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 27 Sep 2010 Planned end date changed from 1 Dec 2009 to 1 Mar 2011 as reported by ClinicalTrials.gov.
    • 27 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top